My name is Margarita.



I'm 36 years old — and a mother of 3.
I've had PNH for 18 years. This is my story.

1     2     3     Next

Margarita was only seventeen when she stopped feeling like the healthy, active person she'd always been. After being diagnosed with paroxysmal nocturnal hemoglobinuria (PNH), she stopped feeling like herself altogether. But there was a solution — and it would help Margarita feel like the vibrant, fun-loving person she had been before.

From the beginning, it was clear that something wasn't right. Margarita was too young to feel so exhausted after almost any activity. She consulted her family doctor — lab tests revealed that her levels of hemoglobin and blood volume were far below normal.

Margarita was given B12, and a whole host of other vitamins, but nothing seemed to help.

Concerned, Margarita's primary care doctor referred her to a hematologist. A blood test confirmed her doctor's fears: Margarita had PNH, a serious disease that causes blood cells to be destroyed by a process called hemolysis.1

Then the blood transfusions started. At first it was only once every five months, but the frequency increased. Soon Margarita was receiving two units of blood almost twice a month — right around the time of her menstrual cycle. Margarita would suffer from migraines and excruciating pain in her stomach and around her liver. The pain was so bad she often had to be admitted to the emergency room, enduring yet another blood transfusion.

1     2     3     Next





IMPORTANT SAFETY INFORMATION

WARNING: SERIOUS MENINGOCOCCAL INFECTIONS

Soliris increases the risk of meningococcal infections. Meningococcal infection may become rapidly life-threatening or fatal if not recognized and treated early

  • Vaccinate patients with a meningococcal vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate according to current medical guidelines for vaccine use
  • Monitor patients for early signs of meningococcal infections, evaluate immediately if infection is suspected, and treat with antibiotics if necessary

The effect of anticoagulant withdrawal during Soliris treatment has not been studied. Therefore, treatment with Soliris should not alter anticoagulant management.

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, a runny nose (nasopharyngitis), back pain, nausea, and tiredness (fatigue).

Please see full prescribing information for SOLIRIS, including boxed WARNING regarding serious meningitis.